The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm
Open accessAbstract
The profound clinical consequences of Gram-positive toxic shock are hypothesized to stem from excessive Th1 responses to superantigens. We used a new superantigen-sensitive transgenic model to explore the role of TCRαβ T cells in responses to staphylococcal enterotoxin B (SEB) in vitro and in two different in vivo models. The proliferative and cytokine responses of HLA-DR1 spleen cells were 100-fold more sensitive than controls and were entirely dependent on TCRαβ T cells. HLA-DR1 mice showed greater sensitivity in vivo to two doses of SEB with higher mortality and serum cytokines than controls. When d-galactosamine was used as a sensitizing agent with a single dose of SEB, HLA-DR1 mice died of toxic shock whereas controls did not. In this sensitized model of toxic shock there was a biphasic release of cytokines, including TNF-α, at 2 h and before death at 7 h. In both models, mortality and cytokine release at both time points were dependent on TCRαβ T cells. Anti-TNF-α pretreatment was protective against shock whereas anti-IFN γ pretreatment and delayed anti-TNF-α treatment were not. Importantly, anti-TNF-α pretreatment inhibited the early TNF-α response but did not inhibit the later TNF-α burst, to which mortality has previously been attributed. Splenic T cells were shown definitively to be the major source of TNF-α during the acute cytokine response. Our results demonstrate unequivocally that TCRαβ T cells are critical for lethality in toxic shock but it is the early TNF-α response and not the later cytokine surge that mediates lethal shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mouse models of toxic shock, TNF is the cytokine driver of superantigen-driven cytokine storm.”
From Cytokine storm (2020) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
The two faces of IL-6 on Th1/Th2 differentiation
Diehl, S. A., & Rincón, M. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00210-9 · Cited by 873
Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., & Wagner, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.91 · Cited by 574
Molecular basis of group A streptococcal virulence
Bisno, A. L., Brito, M. O., & Collins, C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00576-0 · Cited by 505
Decker, K., & KEPPLER, D. O. R. (2005) · Springer eBooks · doi:10.1007/bfb0027661 · Cited by 446
Proft, T., & Fraser, J. D. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02203.x · Cited by 441
Peavy, D. L., Adler, W. H., & Smith, R. T. (1970) · The Journal of Immunology · doi:10.4049/jimmunol.105.6.1453 · Cited by 384
Sheehan, K. C. F., Ruddle, N. H., & Schreiber, R. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3884 · Cited by 381
Spitalny, G. L., & Havell, E. A. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.159.5.1560 · Cited by 370
Lymphoid Development in Mice Congenitally Lacking T Cell Receptor αβ-Expressing Cells
Philpott, K. L., Viney, J. L., Kay, G. F., Rastan, S., Gardiner, E. M., Chae, S., Hayday, A., & Owen, M. J. (1992) · Science · doi:10.1126/science.1604321 · Cited by 362
Role of Superantigens in Human Disease
Schlievert, P. M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.997 · Cited by 344
The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells.
Marrack, P., Blackman, M. A., Kushnir, E., & Kappler, J. W. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.455 · Cited by 341
Interferon gamma receptor deficient mice are resistant to endotoxic shock.
Car, B. D., Eng, V. M., Schnyder, B., Ozmen, L., Huang, S., Gallay, P. A., Heumann, D., Aguet, M., & Ryffel, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1437 · Cited by 290
Fast, D. J., Schlievert, P. M., & Nelson, R. D. (1989) · Infection and Immunity · doi:10.1128/iai.57.1.291-294.1989 · Cited by 274
HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.
Herman, A., Croteau, G., Sékaly, R., Kappler, J. W., & Marrack, P. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.3.709 · Cited by 248
Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen
McCormack, J. E., Callahan, J. E., Kappler, J. W., & Marrack, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.3785 · Cited by 234
Galactosamine induced liver injury.
Decker, K., & KEPPLER, D. O. R. (1972) · PubMed · Cited by 217
Matthys, P., Mitera, T., Heremans, H., Van Damme, J., & Billiau, A. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1158-1164.1995 · Cited by 134
The chronic consequences of severe sepsis
Benjamim, C. F., Hogaboam, C. M., & Kunkel, S. L. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503214 · Cited by 126
Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen.
Bette, M., Schäfer, M. K., van Rooijen, N., Weihe, E., & Fleischer, B. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1531 · Cited by 112
Hackett, S. P., & Stevens, D. L. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.1.232 · Cited by 111
Nagaki, M., Muto, Y., Ohnishi, H., Yasuda, S., Sano, K., Naito, T., Maeda, T., Yamada, T., & Moriwaki, H. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90604-1 · Cited by 104
Gantner, F., Leist, M., Jilg, S., Germann, P., Freudenberg, M. A., & Tiegs, G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90282-1 · Cited by 92
Unnikrishnan, M., Altmann, D. M., Proft, T., Wahid, F. N., Cohen, J., Fraser, J. D., & Sriskandan, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2561 · Cited by 87
Self-citationAltmann, D. M., Douek, D. C., Frater, A. J., Hetherington, C. M., Inoko, H., & Elliott, J. I. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.867 · Cited by 87
Self-citationEnterotoxin residues determining T-cell receptor Vβ binding specificity
Irwin, M. J., Hudson, K., Fraser, J. D., & Gascoigne, N. R. J. (1992) · Nature · doi:10.1038/359841a0 · Cited by 77
Sriskandan, S., Unnikrishnan, M., Krausz, T. N., Dewchand, H., Noorden, S. V., Cohen, J., & Altmann, D. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/322018 · Cited by 77
Self-citationDaSilva, L., Welcher, B. C., Ulrich, R. G., Aman, M. J., David, C. S., & Bavari, S. (2002) · The Journal of Infectious Diseases · doi:10.1086/340828 · Cited by 72
Peripheral T‐Cell Reactivity to Bacterial Superantigens in vivo: The Response/Anergy Paradox
MacDonald, H. R., Lees, R. K., Baschieri, S., Herrmann, T., & Lussow, A. R. (1993) · Immunological Reviews · doi:10.1111/j.1600-065x.1993.tb01512.x · Cited by 72
Protection against lethal toxic shock by targeted disruption of the CD28 gene.
Saha, B., Harlan, D. M., Lee, K. P., June, C. H., & Abe, R. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2675 · Cited by 71
Ulrich, R. G., Bavari, S., & Olson, M. A. (1995) · Nature Structural Biology · doi:10.1038/nsb0795-554 · Cited by 68
Yeung, R. S. M., Penninger, J. M., Kündig, T. M., Khoo, W., Ohashi, P. S., Kroemer, G., & Mak, T. W. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260518 · Cited by 62
Superantigen Recognition by γδ T Cells
Morita, C. T., Li, H., Lamphear, J. G., Rich, R. R., Fraser, J. D., Mariuzza, R. A., & Lee, H. K. (2001) · Immunity · doi:10.1016/s1074-7613(01)00113-3 · Cited by 59
Florquin, S., Amraoui, Z., & Goldman, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250503 · Cited by 54
Miethke, T., Wahl, C., Heeg, K. M., & Wagner, H. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.3776 · Cited by 49
Welcher, B. C., Carra, J. H., DaSilva, L., Hanson, J., David, C. S., Aman, M. J., & Bavari, S. (2002) · The Journal of Infectious Diseases · doi:10.1086/341828 · Cited by 44
Tsytsykova, A. V., & Goldfeld, A. E. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.581 · Cited by 42
Mountz, J. D., Baker, T., Borcherding, D. R., Bluethmann, H., Zhou, T., & Edwards, C. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4829 · Cited by 39
Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants
Roggiani, M., Stoehr, J. A., Leonard, B. A. B., & Schlievert, P. M. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2868-2875.1997 · Cited by 39
Schümann, J., Bluethmann, H., & Tiegs, G. (2000) · Immunology Letters · doi:10.1016/s0165-2478(00)00240-6 · Cited by 36
Structures of Five Mutants of Toxic Shock Syndrome Toxin-1 with Reduced Biological Activity,
Earhart, C. A., Mitchell, D., Murray, D. L., Pinheiro, D. M., Matsumura, M., Schlievert, P. M., & Ohlendorf, D. H. (1998) · Biochemistry · doi:10.1021/bi9721896 · Cited by 32
Detection of circulating superantigens in an intensive care unit population
Azuma, K., Koike, K., Kobayashi, T., Mochizuki, T., Mashiko, K., & Yamamoto, Y. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.12.005 · Cited by 29
Cardell, S., Höidén, I., & Möller, G. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230234 · Cited by 26
Heeg, K. M., Bendigs, S., Miethke, T., & Wagner, H. (1993) · International Immunology · doi:10.1093/intimm/5.8.929 · Cited by 23
Divergence of Human and Nonhuman Primate Lymphocyte Responses to Bacterial Superantigens
Bavari, S., Hunt, R. E., & Ulrich, R. G. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1123 · Cited by 21
Arad, G., Levy, R., & Kaempfer, R. O. R. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00021-4 · Cited by 21
Rajagopalan, G. (2002) · International Immunology · doi:10.1093/intimm/dxf047 · Cited by 18
Role and regulation of IL-12 in the in vivo response to staphylococcal enterotoxin B
Muraille, É., Pajak, B., Urbain, J., Moser, M., & Léo, O. (1999) · International Immunology · doi:10.1093/intimm/11.9.1403 · Cited by 17
Rust, C., Orsini, D. L. M., Kooy, Y. M. C., & Koning, F. (1993) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1993.tb01698.x · Cited by 14
CD8+ Cells are the Main Producers of IL10 and IFNγ after Superantigen Stimulation
Höidén, I., & Möller, G. (1996) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1996.d01-339.x · Cited by 14
Flagged first, then by citations
Research works printed but not linked: 50
- 2003, N. Engl. J. Med., 1546
- 2004, J. Leukocyte Biol., 408
- 2003, Clin. Exp. Immunol., 299
- 1993, J. Infect. Dis., 997
- 2004, Int. J. Infect. Dis., 292
- 1992, Nature, 841
- 1995, Nat. Struct. Biol., 554
- 1989, Infect. Immun., 291
- 1993, J. Infect. Dis., 232
- 1995, Infect. Immun., 1158
- 1992, J. Exp. Med., 91
- 1993, Immunol. Rev., 105
- 1970, J. Immunol., 1453
- 1995, Clin. Immunol. Immunopathol., 248
- 1990, J. Exp. Med., 709
- 2001, J. Infect. Dis., 166
- 2002, J. Immunol., 2561
- 2002, J. Infect. Dis., 1754
- 1996, Eur. J. Immunol., 1074
- 1972, Prog. Liver Dis., 183
- 1974, Rev. Physiol. Biochem. Pharmacol., 77
- 1995, Gastroenterology, 166
- 2003, Lancet Infect. Dis., 191
- 2002, Immunol. Lett., 75
- 1990, J. Exp. Med., 455
- 1993, J. Exp. Med., 1531
- 2000, J. Exp. Med., 581
- 1997, Infect. Immun., 2868
- 1998, Biochemistry, 7194
- 1994, J. Exp. Med., 1437
- 1995, J. Immunol., 4829
- 1995, Eur. J. Immunol., 1148
- 1995, J. Exp. Med., 867
- 1992, Science, 1448
- 1989, J. Immunol., 3884
- 1984, J. Exp. Med., 1560
- 2002, J. Infect. Dis., 501
- 1993, Scand. J. Immunol., 89
- 2001, Immunity, 331
- 1999, Int. Immunol., 1403
- 1993, J. Immunol., 3785
- 2002, Int. Immunol., 801
- 1996, Scand. J. Immunol., 501
- 1993, Eur. J. Immunol., 523
- 1993, Int. Immunol., 929
- 1993, J. Immunol., 3776
- 1996, J. Exp. Med., 2675
- 2002, Mol. Immunol., 531
- 1994, Gastroenterology, 450
- 2000, Immunol. Lett., 165
Cited by
Sorted by citations
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 464
Kawasaki disease: pathophysiology and insights from mouse models
Rivas, M. N., & Arditi, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0426-0 · Cited by 315
Sriskandan, S., & Altmann, D. M. (2007) · The Journal of Pathology · doi:10.1002/path.2274 · Cited by 266
Self-citationHypervirulence of a Rough Variant of the Mycobacterium abscessus Type Strain
Catherinot, É., Clarissou, J., Etienne, G., Neulat-Ripoll, F., Emile, J., Daffé, M., Perronne, C., Soudais, C., Gaillard, J.-L., & Rottman, M. (2006) · Infection and Immunity · doi:10.1128/iai.00835-06 · Cited by 207
Metadata
- Authors
- Faulkner, L., Cooper, A., Fantino, C., Altmann, D. M., & Sriskandan, S.
- Affiliations
- Imperial College London (GB)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11
- Volume
- 175
- Issue
- 10
- Pages
- 6870-6877
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2111438490
- Cited by
- 122
- References
- 51
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 5 · 2017: 6 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- staphylococcal enterotoxin B, TNF-α, cytokine storm, Th1 response, D-galactosamine sensitization, splenic T cells, interferon-gamma
- MeSH terms
- Animals, Enterotoxins, Galactosamine, Humans, Mice, Transgenic, Shock, Septic, Spleen, Tumor Necrosis Factor-alpha, HLA-DR1 Antigen, Cytokines, Receptors, Antigen, T-Cell, alpha-beta, Superantigens, Mice, Knockout, Th1 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review